Organization: Health Canada
Year: 2024
Month: January
Request Number: A-2023-000006
Request Summary: Adverse Drug Reaction (ADR) for MEZAVANT. Report number: E2B_06043746. ADR for MESALAMINE. Report number: E2B_06073155. ADRs for IMMUNOGLOBULIN (HUMAN). Report numbers: E2B_06117266, E2B_06037767, E2B_06094059, 001028881. ADRs for ANTIHEMOPHILIC FACTOR (HUMAN). Report numbers: E2B_06035191, E2B_06114000, E2B_06063299, E2B_06056068.
Disposition: Disclosed in part
Number of pages: 181